Trending Now
InflaRX N.V. (NASDAQ: IFRX) Reports positive Phase II IXCHNAGE Study Findings...
InflaRX N.V. (NASDAQ: IFRX) has announced positive findings from the Phase II IXCHANGE trial of its first in class anti-C5a antibody, vilobelimab, in treating...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
SINTX Technologies (SINT) Secures Key Patent, Solidifies Leadership in Advanced Ceramics
SINTX Technologies, Inc. (NASDAQ: SINT), a frontrunner in ceramic manufacturing, recently announced a significant victory in its pursuit of innovation: the United...
MAKE IT MODERN
LATEST REVIEWS
First Patient Treated in First-in-Human Clinical Trial of PTX-35; Heat Biologics...
Since the outbreak of the COVID-19 pandemic, many pharmaceutical companies have joined the race of developing novel vaccines, and US-based Heat Biologics Inc. (NASDAQ:HTBX)...
MAKE IT MODERN
PERFORMANCE TRAINING
CytomX Therapeutics Inc. (NASDAQ: CTMX) Reports Interim Results For Phase 2 Study HNSCC and...
CytomX Therapeutics Inc. (NASDAQ: CTMX) has announced interim results of the second phase study in patients with head and neck squamous cell carcinoma and...
miRagen Therapeutics Inc. (NASDAQ:MGEN) To Halt Development Of Cobomarsen After SOLAR Study Fails To...
miRagen Therapeutics Inc. (NASDAQ:MGEN) has announced that it is carrying an internal review of initial topline data from the second phase SOLAR clinical study...
Viking Therapeutics stock (VKTX) could hit all time high and here’s why
Viking Therapeutics, Inc. (VKTX), a clinical-stage biopharmaceutical company, is making significant strides in its pipeline of treatments for obesity, liver diseases, and...
Titan Pharmaceuticals Inc.’s (NASDAQ:TTNP) Partner Enters Exclusive Commercialization agreement For Probuphine In EU with...
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) has announced that it's Molteni Farmaceutici partner has signed an exclusive commercialization agreement with Accord Healthcare for Sixmo®, which is...
JetBlue (NASDAQ: JBLU)Announces Commitment to Keep Its Headquarters in New York
JetBlue (NASDAQ: JBLU) has announced today that it will retain its headquarters in New York while also moving forward with plans to expand its...
MAKE IT MODERN
